Association for Accessible Medicines
FDANonrulemakingFDA-2019-N-3403

FDA Solicits Input on Potential Role for Abuse-Deterrent Formulations of Central Nervous System Stimulants; Establishment of a Public Docket; Request for Comments

RIN
Last modified
Dec 3, 2019
Comment window
closed 2443d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Nov 21, 2019 and Nov 21, 2019. 0 other organizations filed here. The comment window closed 2443d ago.

What Association for Accessible Medicines filed (1)

Nov 21, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2019-N-3403-0015

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies regarding FDA-2019-N-3403: Solicits Input on Potential Role for Abuse-Deterrent Formulations of Central Nervous System Stimulants.

Abstract

No abstract recorded.

View on regulations.gov →
FDA Solicits Input on Potential Role for Abuse-Deterrent Formulations of Central Nervous System Stimulants; Establishment of a Public Docket; Request for Comments (FDA) — Association for Accessible Medicines | OpenPolis